BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Treatment
10 results:

  • 1. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
    Deng L; Zeng J; Qiu JF; Yang LH; Ma J
    Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
    Jørgensen PL; Kreiberg M; Jørgensen N; Juul A; Oturai PS; Dehlendorff C; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Medici CR; Jørgensen NR; Bandak M
    Acta Oncol; 2023 Jul; 62(7):689-695. PubMed ID: 37151105
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
    Takamochi K; Tsuboi M; Okada M; Niho S; Ishikura S; Oyamada S; Yamaguchi T; Suzuki K;
    Ann Surg Oncol; 2022 Dec; 29(13):8198-8206. PubMed ID: 36097299
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A randomized double-blind single center study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig cell insufficiency (Einstein-intervention).
    Kreiberg M; Jørgensen N; Juul A; Lauritsen J; Oturai P; Helge JW; Christensen JF; Aksglaede L; Schauer T; Wagner T; Rosenvilde J; Grunwald E; Dehlendorff C; Daugaard G; Bandak M
    Clin Genitourin Cancer; 2022 Oct; 20(5):404-414. PubMed ID: 35701334
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of Testosterone Replacement Therapy on Quality of Life and Sexual Function in testicular cancer Survivors With Mild Leydig Cell Insufficiency: Results From a Randomized Double-blind Trial.
    Højer EG; Kreiberg M; Dehlendorff C; Jørgensen N; Juul A; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Bandak M
    Clin Genitourin Cancer; 2022 Aug; 20(4):334-343. PubMed ID: 35514022
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 'Forever Young'-Testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises.
    Busnelli A; Somigliana E; Vercellini P
    Hum Reprod; 2017 Apr; 32(4):719-724. PubMed ID: 28333214
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis.
    Elzinga-Tinke JE; Dohle GR; Looijenga LH
    Asian J Androl; 2015; 17(3):381-93. PubMed ID: 25791729
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Update in testosterone therapy for men.
    Corona G; Rastrelli G; Forti G; Maggi M
    J Sex Med; 2011 Mar; 8(3):639-54; quiz 655. PubMed ID: 21711483
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Bone marrow-sparing intensity-modulated radiation therapy for Stage I seminoma.
    Zilli T; Boudreau C; Doucet R; Alizadeh M; Lambert C; van Nguyen T; Taussky D
    Acta Oncol; 2011 May; 50(4):555-62. PubMed ID: 21413852
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical and laboratoristic strategy in late onset hypogonadism.
    Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
    Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.